Thomas R. Cannell
Chief Commercial Officer, Orexigen Therapeutics, Inc.
Companies
- Carisma Therapeutics Inc.Board member Aug 9, 2018 to Mar 6, 20231
- Carisma Therapeutics Inc.Chief executive officer Aug 9, 2018 to Mar 6, 20231
- Carisma Therapeutics Inc.President Aug 9, 2018 to Mar 6, 20231
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Carisma Therapeutics Inc.672,386 shares2Mar 2, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Mar 2, 2023Sold 278,564 shares at $0.59 of Carisma Therapeutics Inc.2
- Mar 2, 2023Exercised options 606,800 shares at $0.59 of Carisma Therapeutics Inc.2
- Mar 2, 2023Sold 208,923 shares at $0.59 of Carisma Therapeutics Inc.2
- Feb 21, 2023Sold 53,727 shares at $0.59 of Carisma Therapeutics Inc.3
- Feb 18, 2022Granted 606,800 shares of Carisma Therapeutics Inc.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Feb 23, 2023
- 4SEC EDGARForm 4 filed Feb 23, 2022